Physician profile
Angelo Accomando
NPI 1063454247
$1,955.31
in general payments reported to CMS, 2019-2025
33 companies · $70.84 in 2025
The $70.84 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $455 · 2020: $285 · 2021: $641 · 2022: $344 · 2023: $105 · 2024: $53.31 · 2025: $70.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $216 · Education: $13.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $215.59 |
| Education | $13.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $375.36 | 2021-2022 | |
| Glaxosmithkline, LLC. | $232.82 | 2019-2023 | Trelegy Ellipta, Shingrix, Arexvy |
| Novo Nordisk INC | $180.54 | 2019-2023 | Wegovy |
| Merck Sharp & Dohme LLC | $125.94 | 2019-2022 | |
| Lilly USA, LLC | $100.74 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $88.78 | 2019-2021 | |
| Amgen INC. | $72.53 | 2019-2024 | Evenity, Prolia |
| Teva Pharmaceuticals USA, INC. | $66.78 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $62.50 | 2020-2024 | Breztri |
| Amarin Pharma, INC. | $57.23 | 2019-2021 | |
| Viiv Healthcare Company | $55.94 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $47.23 | 2019-2022 | |
| Preventice Services, LLC | $39.30 | 2019 | |
| Mdd US Operations, LLC | $38.45 | 2019-2020 | |
| Tms Neurohealth Centers INC. | $34.57 | 2025 | Tms Neurohealth Centers INC. |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $32.25 | 2019-2020 | |
| Circassia INC. | $28.76 | 2019-2020 | |
| Vanda Pharmaceuticals INC. | $27.75 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $27.03 | 2020 | |
| Novartis Pharmaceuticals Corporation | $24.23 | 2020 | |
| Alkermes, INC. | $23.99 | 2021 | |
| Bausch Health US, LLC | $23.71 | 2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $22.01 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.95 | 2022 | |
| Azurity Pharmaceuticals, INC. | $20.22 | 2025 | |
| Phathom Pharmaceuticals, INC. | $19.34 | 2024 | Voquezna |
| Biohaven Pharmaceuticals, INC. | $18.25 | 2021 | |
| Janssen Pharmaceuticals, INC | $17.71 | 2021 | |
| Itamar Medical INC | $16.05 | 2025 | Watchpatone |
| Sanofi-Aventis U.S. LLC | $15.26 | 2021 | |
| Optinose US, INC. | $15.19 | 2019 | |
| Eisai INC. | $12.75 | 2021 | |
| Allergan, INC. | $11.15 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angelo Accomando listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.